1989;79:1171 9. 963. Capodanno D, Caggegi A, Miano M, et al. Global Risk Classification and Clinical SYNTAX (Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery) Score in Patients Undergoing Percutaneous or Surgical Left Main Revascularization. J Am Coll Cardiol Intv. 2011;4:287 97. 964. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary- artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008;358:331 41. 965. Ellis SG, Tamai H, Nobuyoshi M, et al. Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 199 1996. Circulation. 1997;96: 3867 72. 966. Biondi-Zoccai GG, Lotrionte M, Moretti C, et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing per- cutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J. 2008;155:274 83. 967. Boudriot E, Thiele H, Walther T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol. 2011;57:538 45. 968. Brener SJ, Galla JM, Bryant R III, et al. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. Am J Cardiol. 2008;101: 169 72. 969. Chieffo A, Magni V, Latib A, et al. 5-year outcomes following percu- taneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the milan experience. J Am Coll Cardiol Intv. 2010;3: 595 601. 970. Chieffo A, Morici N, Maisano F, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation. 2006;113: 2542 7. 971. Lee MS, Kapoor N, Jamal F, et al. 